However, both α4GnT- and αGlcNAc-positive cases consistently showed a lower frequency of lymph node metastasis and pelvic dissemination relative to negative cases (P = 0.175 for α4GnT, and P = 0.159 for αGlcNAc) (Table 2). The gene discussed is A4GNT; the disease is metastatic malignant neoplasm in the lymph nodes.